Last Posted: May 06, 2019
- Recent advances in the therapeutic development for Huntington disease.
Mestre Tiago A et al. Parkinsonism & related disorders 2019 Feb 59125-130 - Targeting Huntingtin Expression in Patients with Huntington’s Disease
SJ Tabrizi et al, NEJM, May 6, 2019 - Presymptomatic testing of those at 25% risk of autosomal dominant neurodegenerative disease- testing team beware.
Delatycki Martin B et al. European journal of human genetics : EJHG 2019 27(1) 20-21 - CRISPR/Cas9-Mediated Genome Editing for Huntington's Disease.
Vachey Gabriel et al. Methods in molecular biology (Clifton, N.J.) 2018 1780463-481 - Nonhuman Primate Models of Huntington's Disease and Their Application in Translational Research.
Aron Badin Romina et al. Methods in molecular biology (Clifton, N.J.) 2018 1780267-284 - DOCTORS' LIABILITY TO THE PATIENT'S RELATIVES IN GENETIC MEDICINE: ABC V St George's Healthcare NHS trust[2015] EWHC 1394 (QB).
Gilbar Roy et al. Medical law review 2016 24(1) 112-23 - A Systematic Review of the Psychological Implications of Genetic Testing: A Comparative Analysis Among Cardiovascular, Neurodegenerative and Cancer Diseases.
Oliveri Serena et al. Frontiers in genetics 2018 9624 - 27 years of prenatal diagnosis for Huntington disease in the United Kingdom.
Piña-Aguilar Raul E et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Dec - Huntington's disease: a clinical review.
McColgan P et al. European journal of neurology 2018 25(1) 24-34 - Huntington disease: A quarter century of progress since the gene discovery.
Testa Claudia M et al. Journal of the neurological sciences 2018 Sep 39652-68
.png)
No hay comentarios:
Publicar un comentario